Close
ACHEMA MIDDLE EAST 2026

Ideas To Improve Availability of Critical Drugs Made By EMA

As the EU health ministers go on to gather in Brussels on April 23–24 in order to discuss access when it comes to critical...

Cell & Gene Therapies: FDA Regulatory Implications For 2024

The fact is that most in the biotech industry know that cell and gene therapies- CGT are regulated across the U.S. as biological products...

Clinical Research Ecosystem Making Utmost Gene Therapy Use?

It is a well-established fact that gene therapy research happens to be booming. Since the U.S. Food and Drug Administration- FDA issued its first...

US Okays Biosecurity Bill Against Chinese Bio Company Deals

In March 2024, one of the biosecurity laws restricting transactions with Chinese bio companies happened to pass the U.S. Congress, and now the global...

Fresh Biologics Clinical Manufacturing CDMO Service Trends

In the ever-changing pharma and biologics sector, the Biologics Clinical Manufacturing CDMO Service market has gone on to emerge as quite a prominent player...

CDMOs Using Specialized Solutions To Meet Cold Chain Needs

It is worth noting that the Cell and gene therapies- CGTs have gone on to show immense promise when it comes to treating diverse...

IoT Making The Precision Lab Equipment Segment See A Surge

It is well to be noted that precision happens to be one of the most required equipment qualities when it comes to consistency as...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...